Differential effect of keratinocyte growth factor (KGF) on aromatase activity in cultured canine prostatic epithelial cells

Endocrine Research

Volumn 23, Issue 4, 1997, Pages 311-323

  Canatan, H ^a   Shidaifat, F ^a   Kulp, S K ^a   Zhang, Y ^a   Chang, W Y ^a   Brueggemeier, R W ^a   Lin, Y C ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; KERATINOCYTE GROWTH FACTOR;

ANIMAL CELL; AROMATIZATION; ARTICLE; CELL CULTURE; DOG; DRUG EFFECT; ENZYME ACTIVITY; ENZYME SUBSTRATE; EPITHELIUM CELL; FIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY;

EID: 0031443564     PISSN: 07435800     EISSN: None     Source Type: Journal    
DOI: 10.1080/07435809709031860     Document Type: Article

References (39)

1. Juniewicz PE, Lemp BM, Barbolt TK, LaBrie TK, Batzold FH and Reel JR. 1989 Dose-dependent hormonal induction of benign prostatic hyperplasia in castrated dogs. Prostate 14:341-352.
2. 4-androstene-3,17-dione to estrone by endocrine tissue. Biochim Biophys Acta 17:441-442.
3. MacDonald PC. 1976 Origin of estrogen in men. In: Grayhack JT, Wilson JD and Scherbenske MJ (Eds). Benign prostatic hyperplasia. Proc. of a workshop sponsored by the Kidney Disease and Urology of the NIAMDD, Feb. 20-21., 1975. Washington D.C., U.S. Government Printing Office, pp. 191-192.
4. Farnsworth WB. 1996 Roles of estrogen and SHBG in prostate physiology. Prostate 28:17-23.
5. Suzuki K, Ito K, Ichinose Y, Kurokawa K, Suzuki T, Imai K, Yamanaka H and Honma S. 1995 Endocrine environment of benign prostatic hyperplasia: prostate size and volume are correlated with serum estrogen concentration. Scand J Urol Nephrol 29:65-68.
6. Aaronson SA, Bottaro DP, Miki T, Ron D, Finch PW, Fleming TP, Ahn J, Taylor WG, and Rubin JS. 1991 A fibroblast growth factor family member with unusual target cell specifity. Ann N Y Acad Sci 638:62-77.
7. Rubin JS, Bottaro DP, Chedid M, Miki T, Ron D, Cheon HG, taylor WG, Fortney E, Sakata H, Finch PW and LaRochelle WJ. 1995 Keratinocyte growth factor. Cell Biol Int 19:399-411.
8. Yan G, Fukabori Y, Nikolaropoulos S, Wang F and McKeehan WL. 1992 Heparin-binding keratinocyte growth factor is a candidate stromal to epithelial cell andromedin. Mol Endocrinol 6:2123-2128.
9. Canatan H, Chang WY, Sugimoto Y, Shidaifat F, Kulp SK, Somers WJ and Lin YC. 1996a Production of biologically active recombinant canine keratinocyte growth factor. Biol Reprod 54 (suppl. 1):129.
10. Canatan H, Chang WY, Sugimoto Y, Shidaifat F, Kulp SK, Brueggemeier RW and Lin YC. 1996b Keratinocyte growth factor (KGF/FGF-7) has a paracrine role in canine prostate: Molecular cloning of mRNA encoding canine KGF. DNA Cell Biol 15:247-254.
11. Canatan H, Chang CJG, Hu YF, Chen R, Somers WJ, Brueggemeier RW, and Lin YC. 1994 Expression of keratinocyte growth factor (KGF) in normal and archival canine hyperplastic prostatic tissues. FASEB J 8:A930.
12. Lin YC, Canatan H, Chang CJG, Hu YF, Chen R, Yu CY, Brueggemeier RW, and Somers WJ. 1994 Detection of keratinocyte growth factor (KGF) transcripts from normal human and archival canine benign prostatic hyperplastic tissues. J Med 25:41-64.
13. Canatan H, Sugimoto Y, Chang WY, Shidaifat F, Kulp SK, Chen WK, Brueggemeier RW and Lin YC. 1995 Molecular cloning of mRNA encoding canine keratinocyte growth factor (KGF) and detection of KGF receptor expression in cultured canine prostate epithelial cells. FASEB J 9:A3811.
14. Chang WY, Sugimoto Y, Kulp SK, Reiswig J, Canatan H and Lin YC. 1997 Keratinocyte growth factor: Immunolocalization and function in the prostate. Proc 76th Annu Meet Endocrine Soc Pg.359, Abstract no: P2-300.
15. Zhang Y, Zheng J, Sugimoto Y, Shidaifat F, Kulp SK, Farrar WB, Brueggemeier, RW and Lin YC. 1996 Effect of recombinant human keratinocyte growth factor (KGF) on aromatase activity in human breast cancer cells. FASEB J 10:A757.
16. Akira S, Ohmura H, Uzumcu M, Araki T, Lin YC. 1994 Gossypol inhibits aromatase activity in cultured porcine granulosa cells. Theriogenol 41:1489-1497.
17. Studier FW, Rosenberg AH, Dunn JJ and Dubendorf JW. 1990 Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol 185:60-89.
18. Bradford M. 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
19. Schweikert HU, Milewich L and Wilson JD. 1976 Aromatization of androstenedione by cultured human fibroblasts. J Clin Endocrinol Metab 43:785-795.
20. Longcope C, Pratt JH, Schneider SH and Fineberg SE. 1978 Aromatization of androgens by muscle and adipose tissue. J Clin Endocrinol Metab 43:785-795.
21. Emoto N, Ling N and Baird A. 1990 Growth factor-mediated regulation of aromatase activity in human skin fibroblasts. Proc Soc Expt Biol Med 196:351-358.
22. Schweikert HU. 1979 Conversion of androstenedione to estrone in human fibroblasts cultured from prostate, genital and non-genital skin. Horm Metab Res 11:635-640.
23. Smith T, Chisholm GD and Habib FK. 1982 Failure of human benign prostatic hyperplasia to aromatise testosterone. J Steroid Biochem 17:119-120.
24. Perel E and Killinger DW. 1983 The metabolism of androstenedione and testosterone to C19 metabolites in normal breast, breast carcinoma and benign prostatic hypertrophy tissue. J Steroid Biochem 19:1135-1139.
25. Kaburagi Y, Marino MB, Kirdani RY, Greco JP, Karr JP and Sandberg AA. 1987 The possibility of aromatization of androgen in human prostate. J Steroid Biochem 26:739-742.
26. Stone NN, Laudone VP, Fair WR and Fishman J. 1987 Aromatization of androstenedione to estrogen by benign prostatic hyperplasia, prostate cancer and expressed prostatic secretions. Urol Res 15:165-167.
27. Rowlands MD, Davies JH, Shearer RJ and Dowsett M. 1991 Comparison of aromatase activity in human prostatic, testicular and placental tissues. J Enzyme Inhibition 4:307-313.
28. Brodie AMH, Banks PK Inkster SE, Son C and Koos RD. 1990 Aromatase and other inhibitors in breast and prostatic cancer. J Steroid Biochem Mol Biol 37:1043-1048.
29. Tsugaya M, Harada N, Tozawa K, Yamada Y, Hayashi Y, Tanaka S, Maruyama K and Kohri K. 1996a Aromatase mRNA levels in benign prostatic hyperplasia and prostate cancer. Int J Urol 3:292-296.
30. Tsugaya M, Habib FK, Chisholm GD, Ross M, Kozawa K, Hayashi Y, Kohri K, and Tanaka S. 1996b Testosterone metabolism in primary cultures of epithelial cells and stroma from benign prostatic hyperplasia. Urol Res. 24:265-271.
31. Block JL, Block NL and Lokeshwar BL. 1996 Modulation of aromatase activity by growth factors in an androgen sensitive human prostate cancer cell line, LnCaP. Cancer Lett 102:167-172.
32. Griffiths K, Adlercreutz H, Boyle P, Denis L, Nicholson RI and Morton MS. 1996 Nutrition and Cancer, Isis Medical Media Ltd., Oxford, pp.77-98.
33. Vermeulen A, Deslypere JP and De Meirleir K. 1989 A new look to the andropause: altered function of the gonadotrophs. J Steroid Biochem 32:163-165.
34. Lin YC, Chang CJG, Sugimoto Y, Chang WY, Kulp SK and Brueggemeier RW. 1995 Detection and growth factor regulation of aromatase activity in primary cultured canine prostate stromal cells. FASEB J 9:A547.
35. Peehl DM and Rubin JS. 1995 Keratinocyte growth factor: an androgen-regulated mediator of stromal-epithelial interactions in the prostate. World J Urol 13:312-317.
36. Culig Z, Hobisch A, Cronauer MV, Radmayr C, Trapman J, Hittmair A, Bartsch G and Klocker H. 1994 Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Cancer Res 54:5474-578.
37. Mizuno T, Saito M and Tanemura S. 1994 Induction of prostatic buds in the absence of androgens. CR Soc Biol 188:601-603.
38. Alaraid ET, Rubin JS, Young P, Chedid M, Ron D, Aaronson SA, and Cunha GR. 1994 Keratinocyte growth factor functions in epithelial induction during the seminal vesicle development. Proc Natl Acad Sci USA 91:1074-1078.
39. Sugimura Y, Foster BA, Horn YK, Lipschutz JH, Rubin JS, Finch PW, Aaronson SA, Hayashi N, Kawamura J and Cunha GR. 1996 Keratinocyte growth factor (KGF) can replace testosterone in the ductal branching morphogenesis of the rat ventral prostate. Int J Dev Biol 40:941-951.